Autoantibodies against type I IFNs in patients with life-threatening COVID-19
2020 · Science · 2,815 citations
https://doi.org/10.1126/science.abd4585
M
Martin P. Grobusch
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
675
Papers
26.6K
Citations
73
h-index
370
i10-index
Martin P. Grobusch is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Malaria Research and Control & Mosquito-borne diseases and control & Travel-related health issues. The author has an h-index of 73, co-authored 574 publications.
ORCID: 0000-0002-0046-1099Papers by this author
worksInborn errors of type I IFN immunity in patients with life-threatening COVID-19
2020 · Science · 2,377 citations
https://doi.org/10.1126/science.abd4570
Mapping the human genetic architecture of COVID-19
2021 · Nature · 1,104 citations
https://doi.org/10.1038/s41586-021-03767-x
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial
2020 · The Lancet · 270 citations
https://doi.org/10.1016/s0140-6736(20)30552-3
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial
2020 · The Lancet · 270 citations
https://doi.org/10.1016/s0140-6736(20)30552-3
Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study
2022 · The Lancet Infectious Diseases · 165 citations
https://doi.org/10.1016/s1473-3099(22)00651-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat